A 5-10% correction is pretty normal for equities, so I am not really perturbed by the same. It can be attributed to mostly global factors viz. the geopolitical situation in Israel and Ukraine, oil prices remaining high and interest rates in the western world continuing a rising trajectory.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale